Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Notes Payables (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Notes Payables for 4 consecutive years, with $508.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Notes Payables fell 66.18% year-over-year to $508.0 million, compared with a TTM value of $508.0 million through Dec 2025, down 66.18%, and an annual FY2025 reading of $508.0 million, down 66.18% over the prior year.
  • Notes Payables was $508.0 million for Q4 2025 at GE HealthCare Technologies, down from $2.0 billion in the prior quarter.
  • Across five years, Notes Payables topped out at $2.0 billion in Q2 2025 and bottomed at $5.0 million in Q1 2023.
  • Average Notes Payables over 4 years is $929.4 million, with a median of $1.0 billion recorded in 2024.
  • The sharpest move saw Notes Payables surged 20060.0% in 2024, then tumbled 66.18% in 2025.
  • Year by year, Notes Payables stood at $15.0 million in 2022, then skyrocketed by 6606.67% to $1.0 billion in 2023, then skyrocketed by 49.3% to $1.5 billion in 2024, then crashed by 66.18% to $508.0 million in 2025.
  • Business Quant data shows Notes Payables for GEHC at $508.0 million in Q4 2025, $2.0 billion in Q3 2025, and $2.0 billion in Q2 2025.